News | December 09, 2024
AbbVie announces emotional impact report on mental health of underrepresented CLL cancer patients
CLL is one of the most common leukemias among adults affecting more than 200,000 people in the US
CLL is one of the most common leukemias among adults affecting more than 200,000 people in the US
For people with relapsed or refractory diffuse large B-cell lymphoma
NUBEQA is currently indicated for the treatment of adult patients with mHSPC in combination with docetaxel and for non-metastatic castration-resistant prostate cancer (nmCRPC)
Fischer MVL envisages to offer a diverse portfolio of diagnostic solutions
If approved, enfortumab vedotin with KEYTRUDA would be the first combination in China to offer an alternative to chemotherapy
The workshop was conducted as a part of the NITI–State workshop series
The sBLA is supported by a usability study which confirmed that individuals over 18 years of age could self-administer
Mpower an initiative of Aditya Birla Education Trust works in the space of Mental health
Label expansion for CIBINQO provides new systemic oral option for adolescents (12 to <18 years) with moderate-to-severe atopic dermatitis
The supplemental New Drug Application is based on results from the landmark EMPA-KIDNEY phase III trial
Subscribe To Our Newsletter & Stay Updated
